What is RVTY's market cap?

$17.79B, based on the Nov 4 close of $159.43.

What is RVTY's P/E ratio?

74.9× trailing-twelve-month earnings of $237.55M.

Does Revvity pay a dividend?

Yes. The latest regular dividend was $0.07 per share (ex-date Oct 23), an annualised yield of 0.18%.

How much of RVTY is sold short?

6.4M shares, 5.8% of float, as of Oct 15, 2026.

What sector is RVTY in?

Healthcare, in the Lab Analytical Instruments industry.

NYSE · RVTYHealthcareLab Analytical Instruments

Revvity, Inc. (RVTY)

$159.43−2.48%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$159.43▲ 73.88% in range

Nov 4, 2025Low $82.26 · High $165.78Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Revvity closed at $159.43 on Nov 4, down 2.48%, 3.8% below its 52-week closing high. Volume of 2.9M shares was 1.57× its 20-day average (above normal).

Split-adjusted performance: +4.0% over one month, +60.9% over six months, +71.5% over one year.

In the quarter ended Jul 5, 2026, revenue was $729.69M, up 1.3% from a year earlier, with a net margin of 7.1%.

Short interest was 6.4M shares at the Oct 15 settlement, up 1.4% from the prior report (5.8% of float, 3.6 days to cover).

Market cap$17.79B111.6M shares

Revenue · quarter$729.7M+1.3% YoY

Diluted EPS$0.47+2.2% YoY

P/E · TTM74.9×P/S 6.1×

Net margin7.1%Gross 57.1%

Dividend yield0.18%$0.07 last paid

52-week range82.26 – 165.78−3.8% from high

Volume2.9M1.57× 20-day avg

Volatility · 60d40.7%Annualised

Short % of float5.8%3.6 days to cover

Net cash-$2.18BCash $1.02B

Next earnings—Not scheduled

Split-adjusted performance

1W −3.6%1M +4.0%3M +39.6%6M +60.9%YTD +64.8%1Y +71.5%3Y +94.2%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Lab Analytical Instruments

Percentile among 22 companies (100 = best)

6-month momentum85

Revenue growth32

Net margin76

Value (low P/E)—

Size81

Industry medians: 6-month return +33.8%, revenue growth +4.9%, net margin −19.0%, P/E 38.3×.

Short interest

Details →

Shares short6.4M+1.4% vs prior

Days to cover3.6Settled Oct 15

% of float5.8%

Short vol. 10d35.1%of daily volume

Closest peers by size in Lab Analytical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
RVTYRevvity	$159.43	−2.48%	+60.9%	+1.3%	7.1%	74.9	$17.79B
AVTRAvantor	$15.65	+0.38%	+85.6%	+4.6%	12.0%	31.4	$10.60B	Compare
BIOBio-Rad Laboratories	$379.99	+1.35%	+46.7%	−0.1%	57.1%	45.7	$10.16B	Compare
BIO.BBio-Rad Laboratories	$379.50	+4.22%	—	−0.1%	57.1%	45.6	$10.15B	Compare
BRKRBruker	$63.79	+12.90%	+50.8%	+5.2%	−7.5%	—	$9.72B	Compare
ILMNIllumina	$226.54	−4.90%	+58.9%	+4.2%	19.5%	38.3	$34.25B	Compare
MTDMettler-Toledo International	$1,723.24	+1.48%	+29.9%	+4.5%	22.7%	38.1	$34.53B	Compare
TXG10x Genomics	$67.52	+3.42%	+196.9%	−12.6%	−11.9%	—	$8.80B	Compare
WATWaters	$467.60	+1.67%	+33.8%	+113.4%	−8.3%	276.5	$45.94B	Compare

News about Revvity

All news →

RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View UpZacks Investment Research · 1d ago▲ Positive Revvity (RVTY) Tops Q3 Earnings and Revenue EstimatesZacks Investment Research · 1d agoNeutral Revvity Gears Up to Post Q3 Earnings: What's in Store for the Stock?Zacks Investment Research · 5d ago▲ Positive Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · Oct 27, 2026▲ Positive Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research · Oct 27, 2026▲ Positive

Quick answers

What does Revvity do?: Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health.
What is RVTY's market cap?: $17.79B, based on the Nov 4 close of $159.43.
What is RVTY's P/E ratio?: 74.9× trailing-twelve-month earnings of $237.55M.
Does Revvity pay a dividend?: Yes. The latest regular dividend was $0.07 per share (ex-date Oct 23), an annualised yield of 0.18%.
How much of RVTY is sold short?: 6.4M shares, 5.8% of float, as of Oct 15, 2026.
What sector is RVTY in?: Healthcare, in the Lab Analytical Instruments industry.

About Revvity

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

HQ: Waltham, MA11,000 employeesListed Jun 1, 1972revvity.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology